Riskpilot← Back to searchSign inGet full accessNestor Medical AB
ABActiveOrg 5564288503BrommaManufacture of pharmaceutical preparations · NACE 2120Est. 19911 employees
Revenue 2024
SEK 0
EBITDA margin
—
+55% vs 2023
Equity ratio
23.2%
Financial strength
Net profit 2024
SEK -39K
+56% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -40K | +55% |
| Net profit | SEK -39K | +56% |
| Total assets | SEK 351K | -12% |
| Equity | SEK 82K | +297% |
| Employees | 1 | — |
Legal name
Nestor Medical AB
Org number
5564288503
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
3 juli 1991
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva forskning, utveckling och försäljning av läkemedel eller läkemedelsnära produkter samt därmed förenlig verksamhet.
Address
Bromma
Phone
+46705414107
Email
arne.kullgren@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 116 | 20 | 0 | 0 |
| Staff expenses | — | — | −16 | −0 | −0 |
| EBITDA | −398 | −234 | −130 | −88 | −40 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −398 | −234 | −130 | −88 | −40 |
| Net financials | −300 | −62 | −833 | 0 | 1 |
| Profit before tax | −548 | −266 | −962 | −88 | −39 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −548 | −266 | −962 | −88 | −39 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 067 | 1 809 | 505 | 400 | 351 |
| Equity | 1 016 | 751 | 109 | 21 | 82 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 051 | 1 059 | 396 | 379 | 270 |
| Total debt | 1 051 | 1 059 | 396 | 379 | 270 |
EBITDA margin
-3968700.0%
This company
15.8%
Market median
-25118454% vs market
20202024
Equity ratio
23.2%
This company
38.2%
Market median
-39% vs market
20202024
Return on equity
-47.7%
This company
18.4%
Market median
-359% vs market
20202024
Net profit margin
-3894800.0%
This company
8.1%
Market median
-48084051% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
3.30×
This company
0.62×
Market median
-432% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nestor Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Anton Kullgren | Deputy Board Member | 0 companies |
| Rolf Arne Kullgren | Board of Directors | 0 companies |